Atossa Therapeutics Inc quote is equal to 1.290 USD at 2022-01-24. Based on our forecasts, a long-term increase is expected, the "ATOS" stock price prognosis for 2027-01-20 is 3.998 USD. With a 5-year investment, the revenue is expected to be around +209.92%. Your current $100 investment may be up to $309.92 in 2027.
Is Atossa a good stock to buy?
Fair opening price Current price
----------------------------------- -------------------
$1.23 $1.20 (Undervalued)
What does Atossa therapeutics do?
About Atossa Therapeutics Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19.22 Dec 2021
Is ATOS a meme stock?
The meme stock community has had their fun with ATOS stock twice this year. Yet with little to no chatter about it now, don't expect a third frenzy for the stock popping up anytime soon. Instead of getting squeezed back “to the moon,” expect it to experience more declines.30 Aug 2021
Is Atossa a good investment?
If you are looking for stocks with good return, Atossa Therapeutics Inc can be a profitable investment option. Based on our forecasts, a long-term increase is expected, the "ATOS" stock price prognosis for 2027-01-20 is 3.998 USD. With a 5-year investment, the revenue is expected to be around +209.92%.
Why is Atossa going down?
Shares of Atossa Therapeutics (NASDAQ:ATOS) were tumbling 22.8% as of 11:36 a.m. EDT on Wednesday. The decline came after the company announced final results from its phase 2 clinical study evaluating oral endoxifen in treating breast cancer with administration between diagnosis and surgery.9 Jun 2021
What does Atossa Therapeutics sell?
Atossa Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing medicines for breast cancer and Covid-19. Its Covid-19 drugs under development, including the AT-H201 program, is for severely ill patients on ventilators, and AT-301 COVID-19 is a nasal spray.
Is Atossa Therapeutics a real company?
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C.